366
Views
2
CrossRef citations to date
0
Altmetric
Mechanisms

Urinary caffeine and caffeine metabolites, asthma, and lung function in a nationwide study of U.S. adults

Pages 2127-2134 | Received 10 Jul 2021, Accepted 10 Oct 2021, Published online: 27 Oct 2021

References

  • Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999;51(1):83–133.
  • Fulgoni VL, 3rd, Keast DR, Lieberman HR. Trends in intake and sources of caffeine in the diets of US adults: 2001-2010. Am J Clin Nutr. 2015;101(5):1081–1087. doi:10.3945/ajcn.113.080077.
  • van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369–378. doi:10.1056/NEJMra1816604.
  • Temple JL, Bernard C, Lipshultz SE, Czachor JD, Westphal JA, Mestre MA. The safety of ingested caffeine: A comprehensive review. Front Psychiatry. 2017;8:80.
  • Pagano R, Negri E, Decarli A, La Vecchia C. Coffee drinking and prevalence of bronchial asthma. Chest. 1988;94(2):386–389. doi:10.1378/chest.94.2.386.
  • Schwartz J, Weiss ST. Caffeine intake and asthma symptoms. Ann Epidemiol. 1992;2(5):627–635. doi:10.1016/1047-2797(92)90007-D.
  • Annesi I, Kauffmann F, Oryszczyn MP, Neukirch F, Dore MF. Coffee drinking and prevalence of bronchial asthma. Chest. 1990;97(5):1268–1269. doi:10.1378/chest.97.5.1268c.
  • Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009;169(12):1445–1453. doi:10.1093/aje/kwp068.
  • Nehlig A. Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384–411. doi:10.1124/pr.117.014407.
  • Onatibia-Astibia A, Martinez-Pinilla E, Franco R. The potential of methylxanthine-based therapies in pediatric respiratory tract diseases. Respir Med. 2016;112:1–9. doi:10.1016/j.rmed.2016.01.022.
  • Moschino L, Zivanovic S, Hartley C, Trevisanuto D, Baraldi E, Roehr CC. Caffeine in preterm infants: where are we in 2020? ERJ Open Res. 2020;6(1):00330-2019. doi:10.1183/23120541.00330-2019.
  • Welsh EJ, Bara A, Barley E, Cates CJ. Caffeine for asthma. Cochrane Database Syst Rev. 2010;(1):CD001112.
  • Weinberger M, Hendeles L. Therapeutic effect and dosing strategies for theophylline in the treatment of chronic asthma. J Allergy Clin Immunol. 1986;78(4 Pt 2):762–768. doi:10.1016/0091-6749(86)90058-8.
  • Gong H, Jr., Simmons MS, Tashkin DP, Hui KK, Lee EY. Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. Chest. 1986;89(3):335–342. doi:10.1378/chest.89.3.335.
  • Centers for Disease Control and Prevention. Laboratory Procedure Manual-Caffeine and Caffeine Metabolites. In: Division of Laboratory Sciences National Center for Environmental Health, editor. Atlanta, GA: Centers for Disease Control and Prevention; 2018.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, ATS/ERS Task Force, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, ERS Global Lung Function Initiative, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312.
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108.
  • American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930.
  • McSharry CP, McKay IC, Chaudhuri R, Livingston E, Fraser I, Thomson NC. Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. J Allergy Clin Immunol. 2005;116(1):88–93. doi:10.1016/j.jaci.2005.03.025.
  • Wee JH, Yoo DM, Byun SH, Song CM, Lee HJ, Park B, et al. Analysis of the relationship between asthma and coffee/green tea/soda intake. Int J Environ Res Public Health. 2020;17(20):7471. doi:10.3390/ijerph17207471.
  • Bruce C, Yates DH, Thomas PS. Caffeine decreases exhaled nitric oxide. Thorax. 2002;57(4):361–363. doi:10.1136/thorax.57.4.361.
  • Taylor ES, Smith AD, Cowan JO, Herbison GP, Taylor DR. Effect of caffeine ingestion on exhaled nitric oxide measurements in patients with asthma. Am J Respir Crit Care Med. 2004;169(9):1019–1021. doi:10.1164/rccm.200310-1473OC.
  • Yurach MT, Davis BE, Cockcroft DW. The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide. Respir Med. 2011;105(11):1606–1610. doi:10.1016/j.rmed.2011.06.006.
  • Abuzayan I, Paraskavi U, Turner SW. Changes to exhaled nitric oxide in asthmatic children after drinking a caffeine-containing cola drink. Pediatr Pulmonol. 2010;45(12):1228–1232. doi:10.1002/ppul.21313.
  • Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med. 2003;167(6):813–818. doi:10.1164/rccm.200210-1142PP.
  • Horrigan LA, Kelly JP, Connor TJ. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther. 2006;111(3):877–892. doi:10.1016/j.pharmthera.2006.02.002.
  • Klemmer I, Yagi S, Gressner OA. Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis. Hepatol Res. 2011;41(11):1094–1109. doi:10.1111/j.1872-034X.2011.00856.x.
  • Al-Alawi M, Hassan T, Chotirmall SH. Transforming growth factor β and severe asthma: a perfect storm. Respir Med. 2014;108(10):1409–1423. doi:10.1016/j.rmed.2014.08.008.
  • Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986;22(2):177–182. doi:10.1111/j.1365-2125.1986.tb05246.x.
  • Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, et al. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther. 2003;73(5):468–474. doi:10.1016/S0009-9236(03)00013-4.
  • Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and Overdiagnosis of Asthma. Am J Respir Crit Care Med. 2018;198(8):1012–1020. doi:10.1164/rccm.201804-0682CI.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.